Epidemiology of Hepatocellular Adenoma
- 17 August 1979
- journal article
- research article
- Published by American Medical Association (AMA)
- Vol. 242 (7) , 644-648
- https://doi.org/10.1001/jama.1979.03300070040020
Abstract
A case-control study of hepatocellular adenoma (HCA), a serious though nonmalignant liver tumor, was conducted by the Center for Disease Control and the Armed Forces Institute of Pathology (AFIP). Interviews with 79 women with HCA and with 220 age- and neighborhood-matched controls were completed. Limited information was obtained on nine additional patients who had died. Women with HCA and hemorrhage have a greater risk of morbidity and death than those with other symptoms. Increasing duration of OC use increases the risk of HCA. Use of OCs with high hormonal potency and age over 30 years may further increase a woman's risk of HCA. Long-term users of OCs have an estimated annual incidence of HCA of 3 to 4 per 100,000. (JAMA242:644-648, 1979)Keywords
This publication has 9 references indexed in Scilit:
- Benign Tumors of the LiverPublished by Springer Nature ,2015
- Primary neoplasms of the liverPublished by Springer Nature ,1993
- Oral-Contraceptive-Induced Benign Liver Tumors—The Magnitude of the ProblemJAMA, 1978
- Nine year follow-up of a case of benign liver cell adenoma related to oral contraceptivesCancer, 1977
- Liver-Cell Adenomas Associated with Use of Oral ContraceptivesNew England Journal of Medicine, 1976
- Liver Cell AdenomaJAMA, 1976
- Accuracy of recall of histories of oral contraceptive useJournal of Epidemiology and Community Health, 1974
- OCCURRENCE OF HEPATIC IMPAIRMENT IN WOMEN JAUNDICED BY ORAL CONTRACEPTIVES AND IN THEIR MOTHERS AND SISTERSActa Medica Scandinavica, 1974
- The discriminating use of combination and sequential preparations in the hormonal inhibition of ovulationContraception, 1971